End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
93.09 CNY | -2.71% | -8.20% | -36.15% |
06-26 | Changchun High & New Technology Unit Gets Nod for Progesterone Injection | MT |
06-25 | Changchun High-Tech Industry Co., Ltd. Approves Board Appointments | CI |
Summary
- From a short-term investment perspective, the company presents a deteriorated fundamental situation
Strengths
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
- The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- Considering the small differences between the analysts' various estimates, the group's business visibility is good.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
Weaknesses
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- For the past year, analysts have significantly revised downwards their profit estimates.
- The overall consensus opinion of analysts has deteriorated sharply over the past four months.
- Over the past twelve months, analysts' opinions have been revised negatively.
- The company's earnings releases usually do not meet expectations.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Pharmaceuticals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-36.15% | 5.29B | B | ||
+54.85% | 811B | C+ | ||
+43.62% | 640B | B | ||
-7.04% | 353B | C+ | ||
+17.96% | 333B | B- | ||
+8.40% | 302B | C+ | ||
+16.30% | 246B | B+ | ||
+2.41% | 225B | A+ | ||
+12.47% | 218B | B- | ||
+8.91% | 168B | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- 000661 Stock
- Ratings Changchun High-Tech Industry (Group) Co., Ltd.